BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33709970)

  • 1. Higher Cancer Mortality in Rural Upper Urinary Tract Urothelial Carcinoma Patients.
    Collà Ruvolo C; Stolzenbach LF; Nocera L; Deuker M; Wenzel M; Tian Z; La Rocca R; Creta M; Capece M; Saad F; Shariat SF; Tilki D; Briganti A; Mirone V; Karakiewicz PI
    Urol Int; 2021; 105(7-8):624-630. PubMed ID: 33709970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
    Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
    Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
    BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.
    Syed JS; Nguyen KA; Suarez-Sarmiento A; Johnson K; Leapman MS; Raman JD; Shuch B
    BJU Int; 2018 Jan; 121(1):124-129. PubMed ID: 28972702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Widmer H; Arjane P; Graefen M; Perrotte P; Montorsi F; Karakiewicz PI
    BJU Int; 2010 Mar; 105(6):799-804. PubMed ID: 19725824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
    Lwin AA; Hsu CH; Chipollini J
    Clin Genitourin Cancer; 2020 Feb; 18(1):45-49.e1. PubMed ID: 31786118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
    Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2021 Apr; 19(2):117-124. PubMed ID: 33358490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].
    Wang Y; He HY
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):681-686. PubMed ID: 27760608
    [No Abstract]   [Full Text] [Related]  

  • 12. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between rural and urban prostate cancer patients.
    Stolzenbach LF; Deuker M; Collà-Ruvolo C; Nocera L; Tian Z; Maurer T; Tilki D; Briganti A; Saad F; Mirone V; Chun FKH; Graefen M; Karakiewicz PI
    World J Urol; 2021 Jul; 39(7):2507-2514. PubMed ID: 33155063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma.
    Simhan J; Smaldone MC; Egleston BL; Canter D; Sterious SN; Corcoran AT; Ginzburg S; Uzzo RG; Kutikov A
    BJU Int; 2014 Aug; 114(2):216-20. PubMed ID: 24053485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis.
    Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Soulières D; Montanari E; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
    Eur Urol Focus; 2020 Mar; 6(2):298-304. PubMed ID: 30266210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of tumor size on outcomes in patients with upper urinary tract urothelial carcinoma.
    Milenkovic-Petronic D; Milojevic B; Djokic M; Sipetic-Grujicic S; Milojevic IG; Bumbasirevic U; Dzamic Z
    Int Urol Nephrol; 2014 Mar; 46(3):563-9. PubMed ID: 24057684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
    Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy.
    Ouzzane A; Colin P; Ghoneim TP; Zerbib M; De La Taille A; Audenet F; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M
    World J Urol; 2013 Feb; 31(1):189-97. PubMed ID: 23229227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis.
    Gandaglia G; Bianchi M; Trinh QD; Becker A; Larouche A; Abdollah F; Roghmann F; Tian Z; Shariat SF; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Int J Urol; 2014 Mar; 21(3):249-56. PubMed ID: 24033809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma.
    Ma Z; Yi Y; Qiu Z
    Fr J Urol; 2024 Mar; 34(2):102573. PubMed ID: 38330829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.